D-0622-2020 Class II Terminated
FDA drug recall D-0622-2020 was initiated by Medisca, Inc. on Nov 25, 2019 and is designated Class II. Reason for recall: Failed Impurities/Degradation Specifications The recall status is terminated (terminated Mar 17, 2021). Affected quantity: 640,325 grams.
Recall details
- Product Type
- Drugs
- Report Date
- Dec 25, 2019
- Initiation Date
- Nov 25, 2019
- Termination Date
- Mar 17, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 640,325 grams
Product description
Estriol, USP (Micronized) 1 g, 5 g, 25 g, 100 g, 2000 g, 1 kg, containers, Packed by Medisca Inc., Plattsburgh, NY 12901, USA
Reason for recall
Failed Impurities/Degradation Specifications
Distribution pattern
Nationwide
Code information
Lot #156110 A-P Lot #153328 A-D Lot #161726 A-L
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0622-2020
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026